Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 309

    1.

    Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy.

    Weger M, Stanger O, Deutschmann H, Simon M, Renner W, Schmut O, Semmelrock J, Haas A.

    Br J Ophthalmol. 2001 Jul;85(7):803-6.PMID: 11423453 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.

    Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A.

    Graefes Arch Clin Exp Ophthalmol. 2002 Apr;240(4):286-90. Epub 2002 Feb 21.PMID: 11981642 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion.

    Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Quehenberger F, Semmelrock J, Haas A.

    Ophthalmology. 2002 Jun;109(6):1105-9.PMID: 12045051 [PubMed - indexed for MEDLINE]Related articles

    4.

    Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.

    Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G.

    Gerontology. 2001 Nov-Dec;47(6):324-9.PMID: 11721146 [PubMed - indexed for MEDLINE]Related articles

    5.

    The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.

    Weger M, Stanger O, Deutschmann H, Leitner FJ, Renner W, Schmut O, Semmelrock J, Haas A.

    Am J Ophthalmol. 2002 Jul;134(1):57-61.PMID: 12095808 [PubMed - indexed for MEDLINE]Related articles

    6.
    9.

    677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke.

    Lalouschek W, Aull S, Korninger L, Mannhalter C, Pabinger-Fasching I, Schmid RW, Schnider P, Zeiler K.

    J Neurol Sci. 1998 Mar 5;155(2):156-62.PMID: 9562260 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia.

    Yoo JH, Choi GD, Kang SS.

    Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1921-5.PMID: 10938012 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.

    Tan NC, Venketasubramanian N, Saw SM, Tjia HT.

    Stroke. 2002 Aug;33(8):1956-62.PMID: 12154245 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mild hyperhomocyst(e)inemia: a possible risk factor for cervical artery dissection.

    Gallai V, Caso V, Paciaroni M, Cardaioli G, Arning E, Bottiglieri T, Parnetti L.

    Stroke. 2001 Mar;32(3):714-8.PMID: 11239192 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.

    Kadziela J, Janas J, Dzielińska Z, Szperl M, Gaździk D, Chotkowska E, Piotrowski W, Ruzyłło W.

    Kardiol Pol. 2003 Jul;59(7):17-26; discussion 26.PMID: 14560345 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects.

    Lalouschek W, Aull S, Serles W, Schnider P, Mannhalter C, Lang T, Deecke L, Zeiler K.

    J Lab Clin Med. 1999 Jun;133(6):575-82.PMID: 10360632 [PubMed - indexed for MEDLINE]Related articles

    15.

    Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

    Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI.

    Stroke. 2000 May;31(5):1069-75.PMID: 10797167 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.

    Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE.

    Arch Intern Med. 2000 Apr 10;160(7):961-4.PMID: 10761961 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.

    Billion S, Tribout B, Cadet E, Queinnec C, Rochette J, Wheatley P, Bataille P.

    Nephrol Dial Transplant. 2002 Mar;17(3):455-61.PMID: 11865092 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?

    Kunz K, Petitjean P, Lisri M, Chantrel F, Koehl C, Wiesel ML, Cazenave JP, Moulin B, Hannedouche TP.

    Nephrol Dial Transplant. 1999 Aug;14(8):1934-42.PMID: 10462274 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.

    Li XM, Wei YF, Hao HL, Hao YB, He LS, Li JD, Mei B, Wang SY, Wang C, Wang JX, Zhu JZ, Liang JQ.

    Am J Hematol. 2002 Sep;71(1):11-4.PMID: 12221667 [PubMed - indexed for MEDLINE]Related articles

    20.

    Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

    Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC.

    Am J Epidemiol. 1996 May 1;143(9):845-59.PMID: 8610698 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data